Emmessar Biotech & Nutrition Limited (BOM:524768)

BOM:524768 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	130	118	152	148	124	137
Market Cap Growth	-21.71%	-22.47%	2.25%	19.84%	-9.82%	87.08%
Enterprise Value	56	46	85	90	78	94
Last Close Price	25.93	23.56	30.39	29.72	24.80	27.50
PE Ratio	32.01	27.00	48.02	19.81	24.59	28.90
PS Ratio	5.38	4.89	7.11	7.27	4.93	7.75
PB Ratio	1.60	1.45	1.97	2.01	1.86	2.23
P/TBV Ratio	1.60	1.45	1.97	2.01	1.86	2.23
P/FCF Ratio	50.49	45.87	67.84	23.04	35.41	7.00
P/OCF Ratio	48.87	44.40	67.84	23.04	32.94	6.05
EV/Sales Ratio	2.34	1.90	4.00	4.41	3.10	5.28
EV/EBITDA Ratio	8.25	6.69	14.93	21.36	9.46	16.17
EV/EBIT Ratio	9.67	7.85	18.01	27.80	10.67	19.23
EV/FCF Ratio	21.93	17.80	38.11	13.97	22.29	4.76
Debt / Equity Ratio	-	-	-	0.02	0.01	-
Debt / EBITDA Ratio	-	-	-	0.26	0.10	-
Debt / FCF Ratio	-	-	-	0.17	0.24	-
Net Debt / Equity Ratio	-0.90	-0.90	-1.01	-0.82	-0.77	-0.74
Net Debt / EBITDA Ratio	-10.74	-10.74	-13.62	-14.43	-6.21	-7.93
Net Debt / FCF Ratio	-28.55	-28.55	-34.77	-9.43	-14.63	-2.34
Asset Turnover	0.26	0.26	0.24	0.25	0.33	0.24
Inventory Turnover	0.80	0.80	1.74	1.77	4.24	2.00
Quick Ratio	19.06	19.06	16.51	12.33	12.64	14.30
Current Ratio	20.27	20.27	15.68	13.56	14.15	14.73
Return on Equity (ROE)	5.51%	5.51%	4.18%	10.66%	7.85%	8.01%
Return on Assets (ROA)	3.88%	3.88%	3.30%	2.43%	6.03%	4.05%
Return on Invested Capital (ROIC)	55.52%	122.47%	25.07%	20.84%	23.76%	10.35%
Return on Capital Employed (ROCE)	6.40%	6.40%	5.40%	3.90%	9.70%	7.10%
Earnings Yield	3.36%	3.70%	2.08%	5.05%	4.07%	3.46%
FCF Yield	1.98%	2.18%	1.47%	4.34%	2.82%	14.30%
Buyback Yield / Dilution	-7.72%	-7.72%	-	-	-	0.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.